Diseases

T45696D

Underdosing of other fibrinolysis-affecting drugs, subsequent encounter

T41296A

Underdosing of other general anesthetics, initial encounter

T41296S

Underdosing of other general anesthetics, sequela

T41296D

Underdosing of other general anesthetics, subsequent encounter

T38996A

Underdosing of other hormone antagonists, initial encounter

T38996S

Underdosing of other hormone antagonists, sequela

T38996D

Underdosing of other hormone antagonists, subsequent encounter

T38896A

Underdosing of other hormones and synthetic substitutes, initial encounter

T38896S

Underdosing of other hormones and synthetic substitutes, sequela

T38896D

Underdosing of other hormones and synthetic substitutes, subsequent encounter

T474X6A

Underdosing of other laxatives, initial encounter

T474X6S

Underdosing of other laxatives, sequela

T474X6D

Underdosing of other laxatives, subsequent encounter

T40696A

Underdosing of other narcotics, initial encounter

T40696S

Underdosing of other narcotics, sequela

T40696D

Underdosing of other narcotics, subsequent encounter

T398X6A

Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter

T398X6S

Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela

T398X6D

Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter

T39396A

Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter

T39396S

Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela

T39396D

Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter

T402X6A

Underdosing of other opioids, initial encounter

T402X6S

Underdosing of other opioids, sequela

T402X6D

Underdosing of other opioids, subsequent encounter

T443X6A

Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter

T443X6S

Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

T443X6D

Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter

T441X6A

Underdosing of other parasympathomimetics [cholinergics], initial encounter

T441X6S

Underdosing of other parasympathomimetics [cholinergics], sequela

T441X6D

Underdosing of other parasympathomimetics [cholinergics], subsequent encounter

T458X6A

Underdosing of other primarily systemic and hematological agents, initial encounter

T458X6S

Underdosing of other primarily systemic and hematological agents, sequela

T458X6D

Underdosing of other primarily systemic and hematological agents, subsequent encounter

T40996A

Underdosing of other psychodysleptics [hallucinogens], initial encounter

T40996S

Underdosing of other psychodysleptics [hallucinogens], sequela

T40996D

Underdosing of other psychodysleptics [hallucinogens], subsequent encounter

T43696A

Underdosing of other psychostimulants, initial encounter

T43696S

Underdosing of other psychostimulants, sequela

T43696D

Underdosing of other psychostimulants, subsequent encounter

T438X6A

Underdosing of other psychotropic drugs, initial encounter

T438X6S

Underdosing of other psychotropic drugs, sequela

T438X6D

Underdosing of other psychotropic drugs, subsequent encounter

T378X6A

Underdosing of other specified systemic anti-infectives and antiparasitics, initial encounter

T378X6S

Underdosing of other specified systemic anti-infectives and antiparasitics, sequela

T378X6D

Underdosing of other specified systemic anti-infectives and antiparasitics, subsequent encounter

T40496A

Underdosing of other synthetic narcotics, initial encounter

T40496S

Underdosing of other synthetic narcotics, sequela

T40496D

Underdosing of other synthetic narcotics, subsequent encounter

T368X6A

Underdosing of other systemic antibiotics, initial encounter

T368X6S

Underdosing of other systemic antibiotics, sequela

T368X6D

Underdosing of other systemic antibiotics, subsequent encounter

T498X6A

Underdosing of other topical agents, initial encounter

T498X6S

Underdosing of other topical agents, sequela

T498X6D

Underdosing of other topical agents, subsequent encounter

T50Z96A

Underdosing of other vaccines and biological substances, initial encounter

T50Z96S

Underdosing of other vaccines and biological substances, sequela

T50Z96D

Underdosing of other vaccines and biological substances, subsequent encounter

T50B96A

Underdosing of other viral vaccines, initial encounter

T50B96S

Underdosing of other viral vaccines, sequela

T50B96D

Underdosing of other viral vaccines, subsequent encounter

T496X6A

Underdosing of otorhinolaryngological drugs and preparations, initial encounter

T496X6S

Underdosing of otorhinolaryngological drugs and preparations, sequela

T496X6D

Underdosing of otorhinolaryngological drugs and preparations, subsequent encounter

T480X6A

Underdosing of oxytocic drugs, initial encounter

T480X6S

Underdosing of oxytocic drugs, sequela

T480X6D

Underdosing of oxytocic drugs, subsequent encounter

T360X6A

Underdosing of penicillins, initial encounter

T360X6S

Underdosing of penicillins, sequela

T360X6D

Underdosing of penicillins, subsequent encounter

T467X6A

Underdosing of peripheral vasodilators, initial encounter

T467X6S

Underdosing of peripheral vasodilators, sequela

T467X6D

Underdosing of peripheral vasodilators, subsequent encounter

T50A16A

Underdosing of pertussis vaccine, including combinations with a pertussis component, initial encounter

T50A16S

Underdosing of pertussis vaccine, including combinations with a pertussis component, sequela

T50A16D

Underdosing of pertussis vaccine, including combinations with a pertussis component, subsequent encounter

T433X6A

Underdosing of phenothiazine antipsychotics and neuroleptics, initial encounter

T433X6S

Underdosing of phenothiazine antipsychotics and neuroleptics, sequela

T433X6D

Underdosing of phenothiazine antipsychotics and neuroleptics, subsequent encounter

T444X6A

Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter

T444X6S

Underdosing of predominantly alpha-adrenoreceptor agonists, sequela

T444X6D

Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter

T445X6A

Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter

T445X6S

Underdosing of predominantly beta-adrenoreceptor agonists, sequela

T445X6D

Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter

T39316A

Underdosing of propionic acid derivatives, initial encounter

T39316S

Underdosing of propionic acid derivatives, sequela

T39316D

Underdosing of propionic acid derivatives, subsequent encounter

T392X6A

Underdosing of pyrazolone derivatives, initial encounter

T392X6S

Underdosing of pyrazolone derivatives, sequela

T392X6D

Underdosing of pyrazolone derivatives, subsequent encounter

T366X6A

Underdosing of rifampicins, initial encounter

T366X6S

Underdosing of rifampicins, sequela

T366X6D

Underdosing of rifampicins, subsequent encounter

T39096A

Underdosing of salicylates, initial encounter

T39096S

Underdosing of salicylates, sequela

T39096D

Underdosing of salicylates, subsequent encounter

T473X6A

Underdosing of saline and osmotic laxatives, initial encounter

T473X6S

Underdosing of saline and osmotic laxatives, sequela

T473X6D

Underdosing of saline and osmotic laxatives, subsequent encounter